Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

West Nile Virus capsid protein causes encephalitic inflammation by triggering cell suicide

10.12.2002


The protein that forms the protective capsid surrounding the West Nile virus genetic material may contribute to the deadly inflammation associated with the virus. West Nile virus, which has rapidly spread across the United States, causes neurological symptoms and encephalitis, which can result in paralysis or death. According to researchers at the University of Pennsylvania School of Medicine, the West Nile virus capsid (WNV-Cp) is a destructive protein that can trigger apoptosis – the automatic self-destructive program within cells – inside infected cells, possibly adding to the damage caused by the virus. Their findings are presented in the December issue of Emerging Infectious Diseases, a journal available on the Centers for Disease Control and Prevention (CDC) Web site.



"Despite the fact that West Nile virus is a global health threat, we understand very little of the pathogenesis of the disease caused by this virus," said David Weiner, PhD, associate professor in Penn’s Department of Pathology and Laboratory Medicine. "Since there is currently no specific treatment for West Nile virus, it is important to understand the biology of this virus to help us devise vaccines and new treatments for the West Nile virus infection."

According to the CDC, the West Nile virus has infected over 3700 people and killed over 200, mostly elderly, people since it was first introduced to the United States in 1999. The numbers of those infected, however, may be much higher since the disease often takes a mild form in healthy people who are less likely to seek treatment and the CDC numbers only count for those cases known to state medical agencies. The virus is spread primarily through its insect host, the mosquito, although it is now known to spread through mothers’ breast milk and organ transplantations.


The Penn researchers first began studying WNV-Cp when they noticed a striking similarity between the gene that encodes for it and that of an HIV regulatory protein. "We hope to extend the lessons they have learned in trying to develop therapeutics for HIV in fighting West Nile." Said Weiner. "In addition to the possibility of creating a vaccine for West Nile, our results support the idea that a specific portion of the capsid protein – called the 3’ terminal region – is required for the protein’s pathogenicity. If we can find a way to block that region’s function, this might help slow the virus down."

By itself, the WNV-Cp protein can cause inflammation. Weiner and his colleagues found that WNV-Cp drives apoptosis in cell cultures through what is called the mitochondrial pathway. The protein begins the process of cell suicide by somehow disrupting the membrane potential of the cell’s mitochondria, which then leads to the activation of proteins such as caspase-9 and caspase-3 that start a cascade of reactions to subsequently cause the cell to digest itself.

Since the protein enters the nucleus of the cell, it is possible that WNV-Cp changes the host cell’s transcriptional machinery, resulting in an over production of certain proteins related to an apoptotic program, which consequently feed back to the mitochondria.

Alternatively, as WNV-Cp moves from the cytoplasm to the nucleus, it may inactivate an important part of the cell’s natural control system that keeps apoptosis in check – overpowering the guard as it were – thus inducing the cell suicide.

"Overall, our data suggest that WNV-Cp may interact with host cell proteins to induce apoptosis in the host cell," said Weiner, "Identifying these proteins will likely give more insight into the biology of West Nile."

The proteins pathogenic properties extend outside of the tissue culture. WNV-Cp also directly caused apoptosis and inflammation in mouse muscle cells. More importantly, the WNV-Cp protein caused inflammation and apoptosis in mouse brain in a manner similar to what is observed in natural infections.

Greg Lester | EurekAlert!
Further information:
http://www.med.upenn.edu/

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>